VivaBioCell Overview

  • Founded
  • 2005
  • Status
  • Acquired/​Merged
  • Employees
  • 3
  • Latest Deal Type
  • M&A

VivaBioCell General Information


Provider of next-generation cell and tissue engineering therapies designed to regenerate and repair damaged tissues and organs. The company's cell and tissue engineering therapies can be used to develop immune cells utilized in the treatment of cancer such as natural killer cells enabling its clients to provide safe, efficacious, standardized and affordable medical treatments.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Parent Company
VBC Holdings
Primary Office
  • Via del Cotonificio, 127
  • 33100 Udine
  • Italy
+39 0432 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VivaBioCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 22-Jun-2015 Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 Completed Startup
To view VivaBioCell’s complete valuation and funding history, request access »

VivaBioCell Patents

VivaBioCell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2017513512-A Automatic cell culture and collection device Granted 28-Apr-2014 000000000
JP-6719387-B2 Automatic cell culture and recovery device Active 28-Apr-2014 000000000
EP-3137590-A1 Automated cell culturing and harvesting device Pending 28-Apr-2014 000000000
US-20170037357-A1 Automated cell culturing and harvesting device Pending 28-Apr-2014 000000000 0
JP-2014512009-A Immunodiagnostic method for diagnosing autoimmune systemic scleroderma (ssc) and systemic lupus erythematosus (sle) Pending 15-Apr-2011 G01N33/56966
To view VivaBioCell’s complete patent history, request access »

VivaBioCell Executive Team (1)

Name Title Board Seat Contact Info
Francesco Curcio Chief Scientific Officer, President & Founder
To view VivaBioCell’s complete executive team members history, request access »

VivaBioCell Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial